We are successfully manufacturing and supplying the best quality stock of Biceltis. This is offered for intravenous infusion only and effective in restricting the HER2/neu receptor which in result ultimately heals the breast cancer in patients. Formulated in accordance with medical standards using best quality clinically approved drugs, the Biceltis is offered to clients after inspecting its quality on varied standard parameters.
- Known with the genric name Trastuzumab
- Belongs to the group of monoclonal antibodies
- Extended shelf life
Biceltis 440mg injection is used in the treatment of breast cancer and stomach cancer
How it works
Biceltis 440mg injection is a monoclonal antibody specifically designed to target HER2 receptors on breast cancer cells. Biceltis 440mg injection flags the cancer cells for destruction by the body's immune system.
Common side effects
Fatigue, Nausea, Headache, Weight loss, Fever, Chills, Cough, Infection, Nasopharyngitis, Stomatitis, Anemia, Rash, Diarrhoea, Insomnia, Upper respiratory tract infection, Congestive cardiac failure